Latest Breaking News On - Optimizing treatment - Page 1 : comparemela.com

Patient-Centered Approaches to Frontline Low-Grade Ovarian Cancer: Optimizing Treatment, Quality of Life, and Fertility Preservation

Expert perspectives from Shannon Westin, MD, MPH, FACOG, on frontline treatment options for patients with newly diagnosed low-grade serous ovarian cancer in the context of recent clinical trial data. Dr. Westin discusses optimizing treatment strategies while prioritizing quality of life and fertility preservation for patients.

Expert perspectivesEmerging therapiesLow grade serous ovarian cancerCentered approachesFrontline low grade ovarian cancerOptimizing treatmentOvarian cancerRecurrent ovarian cancerFirst line therapyFrontline therapyFirst line treatmentNovel therapyCombination therapyHormonal therapyHormone therapyClinical trials

Unmet Needs in the Treatment of HR+/HER2- Breast Cancer

Closing their discussion, the panel shares some remaining unmet needs in the treatment and management of patients with HR+/HER- breast cancer.

Optimizing treatmentMultidisciplinary approachBreast cancerHr breast cancerHer2 breast cancerHr her2 breast cancerHer2 negative breast cancerHr positive breast cancerBreast cancer treatmentsBreast cancer therapiesMultidisciplinary careMedical oncologistsRadiation oncologists

Considerations for Use of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer

Dr Naomi Dempsey explains how she decides on an appropriate CDK4/6 inhibitor for patients receiving first-line treatment for metastatic HR+/HER- breast cancer.

Naomi dempseyOptimizing treatmentMultidisciplinary approachBreast cancerHr breast cancerHer2 breast cancerHr her2 breast cancerHer2 negative breast cancerHr positive breast cancerBreast cancer treatmentsBreast cancer therapiesMultidisciplinary careMedical oncologistsRadiation oncologists

Common Toxicities of CDK4/6 Inhibitors in Patients With HR+/HER2- Metastatic Breast Cancer

The panel explains how treatment experience with CDK4/6 inhibitors varies for patients with HR+/HER- breast cancer, and which agents are best tolerated.

Optimizing treatmentMultidisciplinary approachPatients withBreast cancerHr breast cancerHer2 breast cancerHr her2 breast cancerHer2 negative breast cancerHr positive breast cancerBreast cancer treatmentsBreast cancer therapiesMultidisciplinary careMedical oncologistsRadiation oncologists

Monitoring and Treating Lymphedema in Patients With HR+/HER- Breast Cancer

Monitoring and Treating Lymphedema in Patients With HR+/HER- Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Nadia nocera zachariahOptimizing treatmentMultidisciplinary approachTreating lymphedemaPatients withNocera zachariah